Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Neurocrine Biosciences Inc Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$122 Billion
Q2 2025

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 91,388 shares of NBIX stock, worth $13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

91,388

Previous 76,922 18.81%

Holding current value

$13 Million

Previous $8.51 Million 35.02%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$87.54 - $128.18 $1.27 Million - $1.85 Million	14,466 Added 18.81%	91,388 $11.5 Million
Q4 2024 Feb 12, 2025	BUY	$111.62 - $139.44 $1.01 Million - $1.27 Million	9,086 Added 13.39%	76,922 $10.5 Million
Q3 2024 Nov 07, 2024	BUY	$114.58 - $153.15 $393,926 - $526,529	3,438 Added 5.34%	67,836 $7.81 Million
Q2 2024 Aug 12, 2024	BUY	$130.86 - $143.19 $1.2 Million - $1.32 Million	9,204 Added 16.68%	64,398 $8.87 Million
Q1 2024 May 09, 2024	BUY	$130.4 - $143.74 $1.83 Million - $2.01 Million	14,015 Added 34.03%	55,194 $7.61 Million
Q4 2023 Feb 08, 2024	BUY	$106.07 - $132.76 $2,969 - $3,717	28 Added 0.07%	41,179 $5.43 Million
Q3 2023 Nov 07, 2023	BUY	$94.02 - $117.1 $7,991 - $9,953	85 Added 0.21%	41,151 $4.63 Million
Q2 2023 Aug 09, 2023	BUY	$89.53 - $104.87 $547,296 - $641,070	6,113 Added 17.49%	41,066 $3.87 Million
Q1 2023 May 08, 2023	BUY	$94.11 - $123.02 $405,237 - $529,724	4,306 Added 14.05%	34,953 $3.54 Million
Q4 2022 Feb 07, 2023	BUY	$106.72 - $127.06 $327,630 - $390,074	3,070 Added 11.13%	30,647 $3.66 Million
Q3 2022 Nov 01, 2022	SELL	$92.03 - $107.81 $3,957 - $4,635	-43 Reduced 0.16%	27,577 $2.93 Million
Q2 2022 Aug 04, 2022	BUY	$75.79 - $100.07 $308,692 - $407,585	4,073 Added 17.3%	27,620 $2.69 Million
Q1 2022 May 09, 2022	SELL	$72.45 - $94.81 $21,300 - $27,874	-294 Reduced 1.23%	23,547 $2.21 Million
Q4 2021 Feb 07, 2022	BUY	$79.65 - $106.22 $210,992 - $281,376	2,649 Added 12.5%	23,841 $2.11 Million
Q3 2021 Nov 04, 2021	BUY	$86.18 - $99.03 $30,593 - $35,155	355 Added 1.7%	21,192 $2.03 Million
Q2 2021 Aug 06, 2021	BUY	$89.43 - $102.27 $215,436 - $246,368	2,409 Added 13.07%	20,837 $2.03 Million
Q1 2021 May 06, 2021	BUY	$87.57 - $119.4 $119,795 - $163,339	1,368 Added 8.02%	18,428 $1.79 Million
Q4 2020 Feb 09, 2021	BUY	$86.91 - $108.33 $75,524 - $94,138	869 Added 5.37%	17,060 $1.64 Million
Q3 2020 Nov 10, 2020	BUY	$96.16 - $135.15 $201,359 - $283,004	2,094 Added 14.85%	16,191 $1.56 Million
Q2 2020 Aug 06, 2020	BUY	$85.09 - $130.36 $90,961 - $139,354	1,069 Added 8.21%	14,097 $1.72 Million
Q1 2020 May 11, 2020	SELL	$75.11 - $113.76 $97,117 - $147,091	-1,293 Reduced 9.03%	13,028 $1.13 Million
Q4 2019 Feb 05, 2020	BUY	$86.8 - $118.57 $1.24 Million - $1.7 Million	14,321 New	14,321 $1.57 Million

Others Institutions Holding NBIX

# of Institutions

662

Shares Held

102M

Call Options Held

290K

Put Options Held

214K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.6B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account

Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Neurocrine Biosciences Inc Transaction History